Intermountain

Intermountain Healthcare is a nonprofit health system based in Salt Lake City, Utah, with 22 hospitals, ​about 1,100 employed primary care and secondary care physicians at more than 185 clinics in the Intermountain Medical Group, a broad range of clinics and services, and health insurance plans from SelectHealth. They are the largest healthcare provider in the Intermountain West, with over 33,000 employees and serving the healthcare needs of Utah and southeastern Idaho residents. Their mission is excellence in the provision of healthcare services to communities in the Intermountain region.
CA

Clay Ashdown

VP of Financial Strategy, Growth and Development

CB

Chris Bruerton

Assistant VP, Finance

KC

Kelly Christensen

Director of Finance

MH

Marc Harrison

MD, President and CEO

SJ

Stacy Jennings

Assistant VP of Investments

MP

Marc Probst

VP and Chief Information Officer

BZ

Bert Zimmerli

SVP and CFO

AZ

Albert Zimmerli

EVP and CFO

28 past transactions

Redox

Series B in 2017
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better. It keeps patients at the forefront by helping vendors and providers integrate securely, easily, and at a reduced cost. It was founded in 2014 and is headquartered in Madison, Wisconsin.

Redox

Debt Financing in 2018
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better. It keeps patients at the forefront by helping vendors and providers integrate securely, easily, and at a reduced cost. It was founded in 2014 and is headquartered in Madison, Wisconsin.

Classic Air Medical

Acquisition in 2021
Classic Air Medical is a provider of air medical transports services in the states of Arizona, Utah, Colorado, Idaho, New Mexico, and Wyoming. We have a reputation for excellent patient care and safety as we provide critical care air transport.

Recursion Pharmaceuticals

Series C in 2019
Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.

Armis Security

Series C in 2019
Armis, Inc. develops an Internet of things (IoT) security solution to control and detect activity and threats on devices and networks. It offers protection to organizations from unmanaged and rogue devices, including point of sale products, infusion pumps, security cameras and routers, production line sensors, printers, televisions, and guest devices. The company serves finance, healthcare, manufacturing, technology, rogue devices, rogue network, and shadow IoT industries. The company was founded in 2015 and is headquartered in Palo Alto, California with an additional office in Tel Aviv.

Vivante Health, Inc.

Series A in 2022
Vivante Health, Inc., a digital health company, develops solutions to manage chronic conditions. It offers GIThrive, a technology platform that provides actionable insights to members manage their digestive conditions, as well as empowers people through technology, advanced science, and on-demand human support for cost savings for health plans and self-insured employers. The company’s GIThrive also acts as a digital gut health program that provides expert insights and guidance, monitoring and analysis, and 24/7 gut-side assistance. In addition, it offers GIMate, a portable breathalyzer that identifies trigger food; and GutCheck, an at-home microbiome analysis of gut bacteria that provides a personalized diet, recommendations, and care plans. Vivante Health, Inc. was incorporated in 2015 and is based in Houston, Texas with an additional office in Athens, Greece.

Vori Health

Series A in 2021
Vori Health is an all-inclusive medical and health provider practicing a holistic, integrated approach starting with musculoskeletal care. It offers full-service physical medicine and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support, and premium instructional content. The team consists of carefully selected, board-certified physicians and licensed healthcare providers, and provides health services that are accessible at the click of a button from the comfort, convenience, and privacy of a patient's home. The company was founded in 2020 and is headquartered in San Francisco, California.

Recursion Pharmaceuticals

Series D in 2020
Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.

VisitPay LLC

Venture Round in 2014
VisitPay LLC develops an online patient revenue management platform for patients to manage their accounts on their own. The company offers an online financial engagement platform that provides a consolidated view across their provider and health plan for patients and health systems. The platform enables hospitals and health systems to increase the amount they collect on balances owed by patients. Its platform can integrate with multiple billing systems simultaneously to present bills and payment options for patients to understand, verify, and pay. VisitPay LLC was formerly known as iVinci Partners LLC. The company was founded in 2010 and is based in Boise, Idaho with an additional office in Lehi, Utah.

Axuall

Series A in 2021
Axuall, Inc. provides digital network for verifying identity, credentials, and authenticity to healthcare, insurance, financial services, government, philanthropy, manufacturing, logistics, transportation, security, aviation, and construction sectors. The company was incorporated in 2018 and is headquartered in Cleveland, Ohio.

Tute Genomics, Inc.

Series A in 2015
Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment. It has developed the most advanced analytical methods for genome analysis by incorporating proprietary machine-learning algorithms into a cloud-based application that allows researchers to analyze and interpret entire human genomes and discover genes and biomarkers at an unprecedented rate. It was founded in 2012 and headquartered in Provo, Utah.

Redox

Series C in 2019
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better. It keeps patients at the forefront by helping vendors and providers integrate securely, easily, and at a reduced cost. It was founded in 2014 and is headquartered in Madison, Wisconsin.

Zebra Medical Vision Ltd.

Series C in 2018
Zebra Medical Vision Ltd. develops an imaging analytics platform. Its platform provides imaging research solutions for clinicians; advanced learning and computer vision diagnostic algorithms for developers; and risk management and preventative care tools for healthcare providers. The company offers tools and datasets to the machine-learning researchers to accelerate the development of advanced decision support tools and diagnosis. Zebra Medical Vision Ltd. has strategic collaborations with USARAD Holdings, Inc.; and TELUS Ventures. The company was founded in 2014 and is based in Shefayim, Israel.

Syapse

Series F in 2020
Syapse works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health Network, Syapse has built one of the world’s largest networks dedicated to improving outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need. The company was founded in 2008 and is headquartered in San Francisco, California.

Redox

Series B in 2017
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better. It keeps patients at the forefront by helping vendors and providers integrate securely, easily, and at a reduced cost. It was founded in 2014 and is headquartered in Madison, Wisconsin.

SomaLogic

Series A in 2020
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Empiric Health, Inc.

Seed Round in 2017
Empiric Health, Inc. operates as technology-enabled service platform that lowers cost and improves outcomes for health system customers through data-driven physician practice change. It helps care providers to understand and optimize for high value episodic care. The company was founded in 2017 and is based in Salt Lake City, Utah. As of February 18, 2017, Empiric Health, Inc. operates as a subsidiary of Oxeon Partners LLC.

Tute Genomics, Inc.

Series A in 2014
Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment. It has developed the most advanced analytical methods for genome analysis by incorporating proprietary machine-learning algorithms into a cloud-based application that allows researchers to analyze and interpret entire human genomes and discover genes and biomarkers at an unprecedented rate. It was founded in 2012 and headquartered in Provo, Utah.

Circulation

Series A in 2017
Circulation, Inc. develops Circulation, a platform that allows healthcare providers to tap into Uber driver network to bring patients and clinical trial participants to appointments. The company was founded in 2016 and is based in Boston, Massachusetts. As of September 21, 2018, Circulation, Inc. operates as a subsidiary of LogistiCare Solutions, LLC.

Tissue Analytics, Inc.

Series A in 2018
Securely stream patient photographs and wound analysis directly to your desktop! You can now objectively and automatically measure things like chronic wounds, burns, and skin conditions using only a smartphone. Nurses can stream photographs directly to your desktop, where you can evaluate, track, and manage your patients on Their secure web portal.

Ingram Medical

Series B in 2013
Ingram Medical offers a full range of diabetes testing supplies. Now you can get the quality testing supplies you need, at prices you can afford, delivered right to your home. Serving diabetics for over 15 years. When you submit your information to Ingram Medical by clicking on the FREE METER* icon on our Facebook home page, a Diabetic Benefits Specialist will contact you directly. After collecting some basic information, they will find a medical supplier that best fits your personal needs. You’ll soon be saving time and money on your diabetic testing supplies by receiving reduced costs on your out-of-pocket expenses and having your supplies shipped right to your door.

Zebra Medical Vision Ltd.

Series B in 2016
Zebra Medical Vision Ltd. develops an imaging analytics platform. Its platform provides imaging research solutions for clinicians; advanced learning and computer vision diagnostic algorithms for developers; and risk management and preventative care tools for healthcare providers. The company offers tools and datasets to the machine-learning researchers to accelerate the development of advanced decision support tools and diagnosis. Zebra Medical Vision Ltd. has strategic collaborations with USARAD Holdings, Inc.; and TELUS Ventures. The company was founded in 2014 and is based in Shefayim, Israel.

R1 RCM

Post in 2018
R1 RCM serves as a revenue cycle management partner for hospitals and healthcare systems regardless of the payment models, patient engagement strategies, or settings of care. The company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. R1 RCM was founded on 2003 and is based in Chicago, Illinois.

GYANT.com, Inc.

Series A in 2020
GYANT.com, Inc. develops artificial intelligence (AI) based chatbot application that connects physicians and patients. It offers GYANT, a platform that enables physicians to help patients with diagnosis, prescriptions, and treatment recommendations. The company enables to emit a first diagnostic after asking a few questions and helps and diagnoses people suffering from diseases. It serves hospitals, health systems, integrated delivery networks, and providers. GYANT.com, Inc. was incorporated in 2016 and is based in Corte Madera, California.

Syapse

Series D in 2017
Syapse works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health Network, Syapse has built one of the world’s largest networks dedicated to improving outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need. The company was founded in 2008 and is headquartered in San Francisco, California.

Velano Vascular

Corporate Round in 2019
Velano Vascular's technologies transform care by reducing the stress and anxiety related to blood draws during hospitalization. The company's needle-free device reduces pain and discomfort for patients, and enhances safety and efficiency for providers. Founded by a patient and a physician, Velano Vascular is backed by First Round Capital, Kapor Capital and White Owl Capital. The company’s collaborators include leading U.S. hospital systems and organizations innovating in patient-centered care.

HealthCare Partners Nevada

Acquisition in 2019
HealthCare Partners Nevada is a medical group that provides total care & is dedicated to the well-being of our patients.